ORANGE PHARMA LIMITED

🇬🇧Regno Unito•Private Limited Company (Ltd.)•Proposal to strike off

Equity ratio (2018)Equity ratio

100%

YoY total assets (2022 vs 2023)YoY total assets

+69,6%

YoY net current assets (2022 vs 2023)YoY net current assets

Riepilogo

CountryRegno Unito

StatusProposal to strike off

Registration Number05542879

Founded22/08/2005

PurposeNon-specialised wholesale trade

AddressAmbe House, Commerce Way, Edenbridge, Kent, TN8 6ED

Confirmation StatementNext due: 05/09/2025; Last made up: 22/08/2024

Dati legali e stato

Legal FormPrivate Limited Company (Ltd.)

StatusProposal to strike off

Registration Date22/08/2005

Registry AuthorityCompanies House

Registered Capital—

Source: UK Companies House · Last updated: 02/12/2025

Timeline (9 events)

01/03/2025

Status changed

active → active - proposal to strike off

31/03/2023

Annual accounts filed

Annual Accounts · Accounting year ending 31/03/2023

View file in Documents

22/08/2005

Company incorporated

Incorporation date: 2005-08-22

Metric	2018	2019	2020	2021	2022	2023
Total assets	£13.680	£-22.972	£-25.506	£-25.506	£-25.506	£-7761
Net Assets Liabilities	£13.680	£-22.972	£-25.506	£-25.506	£-25.506	£-7761
Equity	£13.680	£-22.972	£-25.506	£-25.506	£-25.506	£-7761
Current Assets	£1.510.534	£86.119	£85.445	£85.446	£85.446	£1105
Net Current Assets Liabilities	£13.680	£-22.972	£-25.506	£-25.506	£-25.506	£-7761
Total Assets Less Current Liabilities	£13.680	£-22.972	£-25.506	£-25.506	£-25.506	£-7761
Cash Bank On Hand	£3413	£1778	£1105	£1105	£1105	£1105
Debtors	£1.507.121	£84.341	£84.341	£84.341	£84.341	—
Other Debtors	£1.451.711	£84.341	£84.341	£84.341	£84.341	—
Creditors	£1.496.854	£109.091	£110.951	£110.952	£110.952	£8866
Trade Creditors Trade Payables	£9907	£1342	—	—	—	—
Other Creditors	£1.472.139	£98.655	£102.085	£102.085	£102.085	—
Average Number Employees During Period	1	—	1	1	1	1
Accrued Liabilities Deferred Income	£1335	£1320	£1075	£1075	£1075	£1075
Balances Amounts Owed By Related Parties	£-40.428	—	—	—	—	—
Balances Amounts Owed To Related Parties	£15.000	—	—	—	—	—
Bank Overdrafts	—	£18	£18	£18	£18	£18
Cash Cash Equivalents	—	£1778	£1087	£1087	£1087	£1087
Other Taxation Social Security Payable	£13.473	£7774	—	—	—	—
Taxation Social Security Payable	—	—	£7773	£7774	£7774	£7773
Trade Debtors Trade Receivables	£55.410	—	—	—	—	—

Metric

2018

2019

2020

2021

2022

2023

Total assets

£13.680

£-22.972

£-25.506

£-7761

Net Assets Liabilities

£13.680

£-22.972

£-25.506

£-7761

Equity

£13.680

£-22.972

£-25.506

£-7761

Current Assets

£1.510.534

£86.119

£85.445

£85.446

£1105

Net Current Assets Liabilities

£13.680

£-22.972

£-25.506

£-7761

Total Assets Less Current Liabilities

£13.680

£-22.972

£-25.506

£-7761

Cash Bank On Hand

£3413

£1778

£1105

Debtors

£1.507.121

£84.341

—

Other Debtors

£1.451.711

£84.341

—

Creditors

£1.496.854

£109.091

£110.951

£110.952

£8866

Trade Creditors Trade Payables

£9907

£1342

—

Other Creditors

£1.472.139

£98.655

£102.085

—

Average Number Employees During Period

—

Accrued Liabilities Deferred Income

£1335

£1320

£1075

Balances Amounts Owed By Related Parties

£-40.428

—

Balances Amounts Owed To Related Parties

£15.000

—

Bank Overdrafts

—

£18

Cash Cash Equivalents

—

£1778

£1087

Other Taxation Social Security Payable

£13.473

£7774

—

Taxation Social Security Payable

—

£7773

£7774

£7773

Trade Debtors Trade Receivables

£55.410

—

Nome	Partecipazione	Voto	Dal

Nome	Partecipazione	Paese	Dal

ORANGE PHARMA LIMITED

Riepilogo

Dati legali e stato

Timeline (9 events)

Status changed

Annual accounts filed

Company incorporated

Rete

Proprietà e organi

Persons with significant control

Ownership Timeline (1 changes)

Appointed Chetas Patel (person)

Soci (azionariato)

Beneficiario effettivo

Geografia

Bilancio e conti

Key figures

Documenti

Company Report of ORANGE PHARMA LIMITED

Annual Accounts

Annual Accounts

Annual Accounts

Annual Accounts

Companexia Document AI

Annual Accounts

Annual Accounts

Altre aziende e persone

Financial Health

Growth

Working capital & liquidity

Capital structure